WGS vs. LLY
Compare and contrast key facts about GeneDx Holdings Corp. (WGS) and Eli Lilly and Company (LLY).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: WGS or LLY.
Correlation
The correlation between WGS and LLY is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
WGS vs. LLY - Performance Comparison
Loading data...
Key characteristics
WGS:
2.13
LLY:
-0.27
WGS:
2.71
LLY:
-0.04
WGS:
1.37
LLY:
0.99
WGS:
2.14
LLY:
-0.32
WGS:
12.46
LLY:
-0.61
WGS:
16.81%
LLY:
13.17%
WGS:
112.44%
LLY:
38.40%
WGS:
-99.85%
LLY:
-68.27%
WGS:
-92.09%
LLY:
-25.10%
Fundamentals
WGS:
$1.93B
LLY:
$650.81B
WGS:
-$1.39
LLY:
$12.32
WGS:
5.86
LLY:
13.28
WGS:
7.51
LLY:
42.54
WGS:
$330.14M
LLY:
$49.00B
WGS:
$211.05M
LLY:
$40.03B
WGS:
-$20.55M
LLY:
$16.67B
Returns By Period
In the year-to-date period, WGS achieves a -12.40% return, which is significantly lower than LLY's -7.01% return.
WGS
-12.40%
-30.51%
-6.58%
236.82%
3.50%
N/A
N/A
LLY
-7.01%
-13.40%
-4.27%
-10.31%
34.36%
38.06%
27.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
WGS vs. LLY — Risk-Adjusted Performance Rank
WGS
LLY
WGS vs. LLY - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GeneDx Holdings Corp. (WGS) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
WGS vs. LLY - Dividend Comparison
WGS has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.78%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
WGS GeneDx Holdings Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LLY Eli Lilly and Company | 0.78% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.95% | 2.46% | 2.77% | 2.37% | 2.84% |
Drawdowns
WGS vs. LLY - Drawdown Comparison
The maximum WGS drawdown since its inception was -99.85%, which is greater than LLY's maximum drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for WGS and LLY. For additional features, visit the drawdowns tool.
Loading data...
Volatility
WGS vs. LLY - Volatility Comparison
GeneDx Holdings Corp. (WGS) has a higher volatility of 60.50% compared to Eli Lilly and Company (LLY) at 17.41%. This indicates that WGS's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
WGS vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between GeneDx Holdings Corp. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
WGS vs. LLY - Profitability Comparison
WGS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, GeneDx Holdings Corp. reported a gross profit of 58.48M and revenue of 87.12M. Therefore, the gross margin over that period was 67.1%.
LLY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a gross profit of 10.50B and revenue of 12.73B. Therefore, the gross margin over that period was 82.5%.
WGS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, GeneDx Holdings Corp. reported an operating income of -4.55M and revenue of 87.12M, resulting in an operating margin of -5.2%.
LLY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported an operating income of 5.41B and revenue of 12.73B, resulting in an operating margin of 42.5%.
WGS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, GeneDx Holdings Corp. reported a net income of -6.53M and revenue of 87.12M, resulting in a net margin of -7.5%.
LLY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Eli Lilly and Company reported a net income of 2.76B and revenue of 12.73B, resulting in a net margin of 21.7%.